1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Cell Theraputics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Stem Cells 1.2.3 Immunocyte 1.3 Market by Application 1.3.1 Global Cell Theraputics Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Allogeneic Cell Therapy 1.3.3 Autologous Cell Therapy 1.3.4 Xenogeneic Cell Therapy 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Cell Theraputics Market Perspective (2016-2027) 2.2 Cell Theraputics Growth Trends by Regions 2.2.1 Cell Theraputics Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Cell Theraputics Historic Market Share by Regions (2016-2021) 2.2.3 Cell Theraputics Forecasted Market Size by Regions (2022-2027) 2.3 Cell Theraputics Industry Dynamic 2.3.1 Cell Theraputics Market Trends 2.3.2 Cell Theraputics Market Drivers 2.3.3 Cell Theraputics Market Challenges 2.3.4 Cell Theraputics Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Cell Theraputics Players by Revenue 3.1.1 Global Top Cell Theraputics Players by Revenue (2016-2021) 3.1.2 Global Cell Theraputics Revenue Market Share by Players (2016-2021) 3.2 Global Cell Theraputics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Cell Theraputics Revenue 3.4 Global Cell Theraputics Market Concentration Ratio 3.4.1 Global Cell Theraputics Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Cell Theraputics Revenue in 2020 3.5 Cell Theraputics Key Players Head office and Area Served 3.6 Key Players Cell Theraputics Product Solution and Service 3.7 Date of Enter into Cell Theraputics Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Cell Theraputics Breakdown Data by Type 4.1 Global Cell Theraputics Historic Market Size by Type (2016-2021) 4.2 Global Cell Theraputics Forecasted Market Size by Type (2022-2027) 5 Cell Theraputics Breakdown Data by Application 5.1 Global Cell Theraputics Historic Market Size by Application (2016-2021) 5.2 Global Cell Theraputics Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Cell Theraputics Market Size (2016-2027) 6.2 North America Cell Theraputics Market Size by Type 6.2.1 North America Cell Theraputics Market Size by Type (2016-2021) 6.2.2 North America Cell Theraputics Market Size by Type (2022-2027) 6.2.3 North America Cell Theraputics Market Size by Type (2016-2027) 6.3 North America Cell Theraputics Market Size by Application 6.3.1 North America Cell Theraputics Market Size by Application (2016-2021) 6.3.2 North America Cell Theraputics Market Size by Application (2022-2027) 6.3.3 North America Cell Theraputics Market Size by Application (2016-2027) 6.4 North America Cell Theraputics Market Size by Country 6.4.1 North America Cell Theraputics Market Size by Country (2016-2021) 6.4.2 North America Cell Theraputics Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Cell Theraputics Market Size (2016-2027) 7.2 Europe Cell Theraputics Market Size by Type 7.2.1 Europe Cell Theraputics Market Size by Type (2016-2021) 7.2.2 Europe Cell Theraputics Market Size by Type (2022-2027) 7.2.3 Europe Cell Theraputics Market Size by Type (2016-2027) 7.3 Europe Cell Theraputics Market Size by Application 7.3.1 Europe Cell Theraputics Market Size by Application (2016-2021) 7.3.2 Europe Cell Theraputics Market Size by Application (2022-2027) 7.3.3 Europe Cell Theraputics Market Size by Application (2016-2027) 7.4 Europe Cell Theraputics Market Size by Country 7.4.1 Europe Cell Theraputics Market Size by Country (2016-2021) 7.4.2 Europe Cell Theraputics Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Cell Theraputics Market Size (2016-2027) 8.2 Asia-Pacific Cell Theraputics Market Size by Type 8.2.1 Asia-Pacific Cell Theraputics Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Cell Theraputics Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Cell Theraputics Market Size by Type (2016-2027) 8.3 Asia-Pacific Cell Theraputics Market Size by Application 8.3.1 Asia-Pacific Cell Theraputics Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Cell Theraputics Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Cell Theraputics Market Size by Application (2016-2027) 8.4 Asia-Pacific Cell Theraputics Market Size by Region 8.4.1 Asia-Pacific Cell Theraputics Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Cell Theraputics Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Cell Theraputics Market Size (2016-2027) 9.2 Latin America Cell Theraputics Market Size by Type 9.2.1 Latin America Cell Theraputics Market Size by Type (2016-2021) 9.2.2 Latin America Cell Theraputics Market Size by Type (2022-2027) 9.2.3 Latin America Cell Theraputics Market Size by Type (2016-2027) 9.3 Latin America Cell Theraputics Market Size by Application 9.3.1 Latin America Cell Theraputics Market Size by Application (2016-2021) 9.3.2 Latin America Cell Theraputics Market Size by Application (2022-2027) 9.3.3 Latin America Cell Theraputics Market Size by Application (2016-2027) 9.4 Latin America Cell Theraputics Market Size by Country 9.4.1 Latin America Cell Theraputics Market Size by Country (2016-2021) 9.4.2 Latin America Cell Theraputics Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Cell Theraputics Market Size (2016-2027) 10.2 Middle East & Africa Cell Theraputics Market Size by Type 10.2.1 Middle East & Africa Cell Theraputics Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Cell Theraputics Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Cell Theraputics Market Size by Type (2016-2027) 10.3 Middle East & Africa Cell Theraputics Market Size by Application 10.3.1 Middle East & Africa Cell Theraputics Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Cell Theraputics Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Cell Theraputics Market Size by Application (2016-2027) 10.4 Middle East & Africa Cell Theraputics Market Size by Country 10.4.1 Middle East & Africa Cell Theraputics Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Cell Theraputics Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Bristol-Myers Squibb Company (Celgene) 11.1.1 Bristol-Myers Squibb Company (Celgene) Company Details 11.1.2 Bristol-Myers Squibb Company (Celgene) Business Overview 11.1.3 Bristol-Myers Squibb Company (Celgene) Cell Theraputics Introduction 11.1.4 Bristol-Myers Squibb Company (Celgene) Revenue in Cell Theraputics Business (2016-2021) 11.1.5 Bristol-Myers Squibb Company (Celgene) Recent Development 11.2 Bluebird Bio 11.2.1 Bluebird Bio Company Details 11.2.2 Bluebird Bio Business Overview 11.2.3 Bluebird Bio Cell Theraputics Introduction 11.2.4 Bluebird Bio Revenue in Cell Theraputics Business (2016-2021) 11.2.5 Bluebird Bio Recent Development 11.3 Crispr Therapeutics 11.3.1 Crispr Therapeutics Company Details 11.3.2 Crispr Therapeutics Business Overview 11.3.3 Crispr Therapeutics Cell Theraputics Introduction 11.3.4 Crispr Therapeutics Revenue in Cell Theraputics Business (2016-2021) 11.3.5 Crispr Therapeutics Recent Development 11.4 Roche (Spark Therapeutics) 11.4.1 Roche (Spark Therapeutics) Company Details 11.4.2 Roche (Spark Therapeutics) Business Overview 11.4.3 Roche (Spark Therapeutics) Cell Theraputics Introduction 11.4.4 Roche (Spark Therapeutics) Revenue in Cell Theraputics Business (2016-2021) 11.4.5 Roche (Spark Therapeutics) Recent Development 11.5 PTC Therapeutics 11.5.1 PTC Therapeutics Company Details 11.5.2 PTC Therapeutics Business Overview 11.5.3 PTC Therapeutics Cell Theraputics Introduction 11.5.4 PTC Therapeutics Revenue in Cell Theraputics Business (2016-2021) 11.5.5 PTC Therapeutics Recent Development 11.6 Moderna Therapeutics 11.6.1 Moderna Therapeutics Company Details 11.6.2 Moderna Therapeutics Business Overview 11.6.3 Moderna Therapeutics Cell Theraputics Introduction 11.6.4 Moderna Therapeutics Revenue in Cell Theraputics Business (2016-2021) 11.6.5 Moderna Therapeutics Recent Development 11.7 Quanterix 11.7.1 Quanterix Company Details 11.7.2 Quanterix Business Overview 11.7.3 Quanterix Cell Theraputics Introduction 11.7.4 Quanterix Revenue in Cell Theraputics Business (2016-2021) 11.7.5 Quanterix Recent Development 11.8 Brainstorm Cell Therapeutics Inc. 11.8.1 Brainstorm Cell Therapeutics Inc. Company Details 11.8.2 Brainstorm Cell Therapeutics Inc. Business Overview 11.8.3 Brainstorm Cell Therapeutics Inc. Cell Theraputics Introduction 11.8.4 Brainstorm Cell Therapeutics Inc. Revenue in Cell Theraputics Business (2016-2021) 11.8.5 Brainstorm Cell Therapeutics Inc. Recent Development 11.9 Lineage Cell Therapeutics 11.9.1 Lineage Cell Therapeutics Company Details 11.9.2 Lineage Cell Therapeutics Business Overview 11.9.3 Lineage Cell Therapeutics Cell Theraputics Introduction 11.9.4 Lineage Cell Therapeutics Revenue in Cell Theraputics Business (2016-2021) 11.9.5 Lineage Cell Therapeutics Recent Development 11.10 Cti Biopharma 11.10.1 Cti Biopharma Company Details 11.10.2 Cti Biopharma Business Overview 11.10.3 Cti Biopharma Cell Theraputics Introduction 11.10.4 Cti Biopharma Revenue in Cell Theraputics Business (2016-2021) 11.10.5 Cti Biopharma Recent Development 11.11 Atara Biotherapeutics, Inc 11.11.1 Atara Biotherapeutics, Inc Company Details 11.11.2 Atara Biotherapeutics, Inc Business Overview 11.11.3 Atara Biotherapeutics, Inc Cell Theraputics Introduction 11.11.4 Atara Biotherapeutics, Inc Revenue in Cell Theraputics Business (2016-2021) 11.11.5 Atara Biotherapeutics, Inc Recent Development 11.12 Adaptimmune 11.12.1 Adaptimmune Company Details 11.12.2 Adaptimmune Business Overview 11.12.3 Adaptimmune Cell Theraputics Introduction 11.12.4 Adaptimmune Revenue in Cell Theraputics Business (2016-2021) 11.12.5 Adaptimmune Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Cell Theraputics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Stem Cells Table 3. Key Players of Immunocyte Table 4. Global Cell Theraputics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 5. Global Cell Theraputics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Cell Theraputics Market Size by Regions (2016-2021) & (US$ Million) Table 7. Global Cell Theraputics Market Share by Regions (2016-2021) Table 8. Global Cell Theraputics Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 9. Global Cell Theraputics Market Share by Regions (2022-2027) Table 10. Cell Theraputics Market Trends Table 11. Cell Theraputics Market Drivers Table 12. Cell Theraputics Market Challenges Table 13. Cell Theraputics Market Restraints Table 14. Global Cell Theraputics Revenue by Players (2016-2021) & (US$ Million) Table 15. Global Cell Theraputics Market Share by Players (2016-2021) Table 16. Global Top Cell Theraputics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cell Theraputics as of 2020) Table 17. Ranking of Global Top Cell Theraputics Companies by Revenue (US$ Million) in 2020 Table 18. Global 5 Largest Players Market Share by Cell Theraputics Revenue (CR5 and HHI) & (2016-2021) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Cell Theraputics Product Solution and Service Table 21. Date of Enter into Cell Theraputics Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Cell Theraputics Market Size by Type (2016-2021) (US$ Million) Table 24. Global Cell Theraputics Revenue Market Share by Type (2016-2021) Table 25. Global Cell Theraputics Forecasted Market Size by Type (2022-2027) (US$ Million) Table 26. Global Cell Theraputics Revenue Market Share by Type (2022-2027) & (US$ Million) Table 27. Global Cell Theraputics Market Size Share by Application (2016-2021) & (US$ Million) Table 28. Global Cell Theraputics Revenue Market Share by Application (2016-2021) Table 29. Global Cell Theraputics Forecasted Market Size by Application (2022-2027) (US$ Million) Table 30. Global Cell Theraputics Revenue Market Share by Application (2022-2027) & (US$ Million) Table 31. North America Cell Theraputics Market Size by Type (2016-2021) (US$ Million) Table 32. North America Cell Theraputics Market Size by Type (2022-2027) & (US$ Million) Table 33. North America Cell Theraputics Market Size by Application (2016-2021) (US$ Million) Table 34. North America Cell Theraputics Market Size by Application (2022-2027) & (US$ Million) Table 35. North America Cell Theraputics Market Size by Country (2016-2021) & (US$ Million) Table 36. North America Cell Theraputics Market Size by Country (2022-2027) & (US$ Million) Table 37. Europe Cell Theraputics Market Size by Type (2016-2021) (US$ Million) Table 38. Europe Cell Theraputics Market Size by Type (2022-2027) & (US$ Million) Table 39. Europe Cell Theraputics Market Size by Application (2016-2021) (US$ Million) Table 40. Europe Cell Theraputics Market Size by Application (2022-2027) & (US$ Million) Table 41. Europe Cell Theraputics Market Size by Country (2016-2021) & (US$ Million) Table 42. Europe Cell Theraputics Market Size by Country (2022-2027) & (US$ Million) Table 43. Asia-Pacific Cell Theraputics Market Size by Type (2016-2021) (US$ Million) Table 44. Asia-Pacific Cell Theraputics Market Size by Type (2022-2027) & (US$ Million) Table 45. Asia-Pacific Cell Theraputics Market Size by Application (2016-2021) (US$ Million) Table 46. Asia-Pacific Cell Theraputics Market Size by Application (2022-2027) & (US$ Million) Table 47. Asia-Pacific Cell Theraputics Market Size by Region (2016-2021) & (US$ Million) Table 48. Asia-Pacific Cell Theraputics Market Size by Region (2022-2027) & (US$ Million) Table 49. Latin America Cell Theraputics Market Size by Type (2016-2021) (US$ Million) Table 50. Latin America Cell Theraputics Market Size by Type (2022-2027) & (US$ Million) Table 51. Latin America Cell Theraputics Market Size by Application (2016-2021) (US$ Million) Table 52. Latin America Cell Theraputics Market Size by Application (2022-2027) & (US$ Million) Table 53. Latin America Cell Theraputics Market Size by Country (2016-2021) & (US$ Million) Table 54. Latin America Cell Theraputics Market Size by Country (2022-2027) & (US$ Million) Table 55. Middle East & Africa Cell Theraputics Market Size by Type (2016-2021) (US$ Million) Table 56. Middle East & Africa Cell Theraputics Market Size by Type (2022-2027) & (US$ Million) Table 57. Middle East & Africa Cell Theraputics Market Size by Application (2016-2021) (US$ Million) Table 58. Middle East & Africa Cell Theraputics Market Size by Application (2022-2027) & (US$ Million) Table 59. Middle East & Africa Cell Theraputics Market Size by Country (2016-2021) & (US$ Million) Table 60. Middle East & Africa Cell Theraputics Market Size by Country (2022-2027) & (US$ Million) Table 61. Bristol-Myers Squibb Company (Celgene) Company Details Table 62. Bristol-Myers Squibb Company (Celgene) Business Overview Table 63. Bristol-Myers Squibb Company (Celgene) Cell Theraputics Product Table 64. Bristol-Myers Squibb Company (Celgene) Revenue in Cell Theraputics Business (2016-2021) & (US$ Million) Table 65. Bristol-Myers Squibb Company (Celgene) Recent Development Table 66. Bluebird Bio Company Details Table 67. Bluebird Bio Business Overview Table 68. Bluebird Bio Cell Theraputics Product Table 69. Bluebird Bio Revenue in Cell Theraputics Business (2016-2021) & (US$ Million) Table 70. Bluebird Bio Recent Development Table 71. Crispr Therapeutics Company Details Table 72. Crispr Therapeutics Business Overview Table 73. Crispr Therapeutics Cell Theraputics Product Table 74. Crispr Therapeutics Revenue in Cell Theraputics Business (2016-2021) & (US$ Million) Table 75. Crispr Therapeutics Recent Development Table 76. Roche (Spark Therapeutics) Company Details Table 77. Roche (Spark Therapeutics) Business Overview Table 78. Roche (Spark Therapeutics) Cell Theraputics Product Table 79. Roche (Spark Therapeutics) Revenue in Cell Theraputics Business (2016-2021) & (US$ Million) Table 80. Roche (Spark Therapeutics) Recent Development Table 81. PTC Therapeutics Company Details Table 82. PTC Therapeutics Business Overview Table 83. PTC Therapeutics Cell Theraputics Product Table 84. PTC Therapeutics Revenue in Cell Theraputics Business (2016-2021) & (US$ Million) Table 85. PTC Therapeutics Recent Development Table 86. Moderna Therapeutics Company Details Table 87. Moderna Therapeutics Business Overview Table 88. Moderna Therapeutics Cell Theraputics Product Table 89. Moderna Therapeutics Revenue in Cell Theraputics Business (2016-2021) & (US$ Million) Table 90. Moderna Therapeutics Recent Development Table 91. Quanterix Company Details Table 92. Quanterix Business Overview Table 93. Quanterix Cell Theraputics Product Table 94. Quanterix Revenue in Cell Theraputics Business (2016-2021) & (US$ Million) Table 95. Quanterix Recent Development Table 96. Brainstorm Cell Therapeutics Inc. Company Details Table 97. Brainstorm Cell Therapeutics Inc. Business Overview Table 98. Brainstorm Cell Therapeutics Inc. Revenue in Cell Theraputics Business (2016-2021) & (US$ Million) Table 99. Brainstorm Cell Therapeutics Inc. Recent Development Table 100. Lineage Cell Therapeutics Company Details Table 101. Lineage Cell Therapeutics Business Overview Table 102. Lineage Cell Therapeutics Cell Theraputics Product Table 103. Lineage Cell Therapeutics Revenue in Cell Theraputics Business (2016-2021) & (US$ Million) Table 104. Lineage Cell Therapeutics Recent Development Table 105. Cti Biopharma Company Details Table 106. Cti Biopharma Business Overview Table 107. Cti Biopharma Cell Theraputics Product Table 108. Cti Biopharma Revenue in Cell Theraputics Business (2016-2021) & (US$ Million) Table 109. Cti Biopharma Recent Development Table 110. Atara Biotherapeutics, Inc Company Details Table 111. Atara Biotherapeutics, Inc Business Overview Table 112. Atara Biotherapeutics, Inc Cell Theraputics Product Table 113. Atara Biotherapeutics, Inc Revenue in Cell Theraputics Business (2016-2021) & (US$ Million) Table 114. Atara Biotherapeutics, Inc Recent Development Table 115. Adaptimmune Company Details Table 116. Adaptimmune Business Overview Table 117. Adaptimmune Cell Theraputics Product Table 118. Adaptimmune Revenue in Cell Theraputics Business (2016-2021) & (US$ Million) Table 119. Adaptimmune Recent Development Table 120. Research Programs/Design for This Report Table 121. Key Data Information from Secondary Sources Table 122. Key Data Information from Primary Sources List of Figures Figure 1. Global Cell Theraputics Market Share by Type: 2020 VS 2027 Figure 2. Stem Cells Features Figure 3. Immunocyte Features Figure 4. Global Cell Theraputics Market Share by Application: 2020 VS 2027 Figure 5. Allogeneic Cell Therapy Case Studies Figure 6. Autologous Cell Therapy Case Studies Figure 7. Xenogeneic Cell Therapy Case Studies Figure 8. Cell Theraputics Report Years Considered Figure 9. Global Cell Theraputics Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 10. Global Cell Theraputics Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 11. Global Cell Theraputics Market Share by Regions: 2020 VS 2027 Figure 12. Global Cell Theraputics Market Share by Regions (2022-2027) Figure 13. Global Cell Theraputics Market Share by Players in 2020 Figure 14. Global Top Cell Theraputics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cell Theraputics as of 2020 Figure 15. The Top 10 and 5 Players Market Share by Cell Theraputics Revenue in 2020 Figure 16. Global Cell Theraputics Revenue Market Share by Type (2016-2021) Figure 17. Global Cell Theraputics Revenue Market Share by Type (2022-2027) Figure 18. North America Cell Theraputics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 19. North America Cell Theraputics Market Share by Type (2016-2027) Figure 20. North America Cell Theraputics Market Share by Application (2016-2027) Figure 21. North America Cell Theraputics Market Share by Country (2016-2027) Figure 22. United States Cell Theraputics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 23. Canada Cell Theraputics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. Europe Cell Theraputics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Europe Cell Theraputics Market Share by Type (2016-2027) Figure 26. Europe Cell Theraputics Market Share by Application (2016-2027) Figure 27. Europe Cell Theraputics Market Share by Country (2016-2027) Figure 28. Germany Cell Theraputics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 29. France Cell Theraputics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. U.K. Cell Theraputics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. Italy Cell Theraputics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Russia Cell Theraputics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Nordic Cell Theraputics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Asia-Pacific Cell Theraputics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Asia-Pacific Cell Theraputics Market Share by Type (2016-2027) Figure 36. Asia-Pacific Cell Theraputics Market Share by Application (2016-2027) Figure 37. Asia-Pacific Cell Theraputics Market Share by Region (2016-2027) Figure 38. China Cell Theraputics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Japan Cell Theraputics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. South Korea Cell Theraputics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Southeast Asia Cell Theraputics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. India Cell Theraputics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Australia Cell Theraputics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Latin America Cell Theraputics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Latin America Cell Theraputics Market Share by Type (2016-2027) Figure 46. Latin America Cell Theraputics Market Share by Application (2016-2027) Figure 47. Latin America Cell Theraputics Market Share by Country (2016-2027) Figure 48. Mexico Cell Theraputics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Brazil Cell Theraputics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Middle East & Africa Cell Theraputics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Middle East & Africa Cell Theraputics Market Share by Type (2016-2027) Figure 52. Middle East & Africa Cell Theraputics Market Share by Application (2016-2027) Figure 53. Middle East & Africa Cell Theraputics Market Share by Country (2016-2027) Figure 54. Turkey Cell Theraputics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 55. Saudi Arabia Cell Theraputics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. UAE Cell Theraputics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. Bristol-Myers Squibb Company (Celgene) Revenue Growth Rate in Cell Theraputics Business (2016-2021) Figure 58. Bluebird Bio Revenue Growth Rate in Cell Theraputics Business (2016-2021) Figure 59. Crispr Therapeutics Revenue Growth Rate in Cell Theraputics Business (2016-2021) Figure 60. Roche (Spark Therapeutics) Revenue Growth Rate in Cell Theraputics Business (2016-2021) Figure 61. PTC Therapeutics Revenue Growth Rate in Cell Theraputics Business (2016-2021) Figure 62. Moderna Therapeutics Revenue Growth Rate in Cell Theraputics Business (2016-2021) Figure 63. Quanterix Revenue Growth Rate in Cell Theraputics Business (2016-2021) Figure 64. Brainstorm Cell Therapeutics Inc. Revenue Growth Rate in Cell Theraputics Business (2016-2021) Figure 65. Lineage Cell Therapeutics Revenue Growth Rate in Cell Theraputics Business (2016-2021) Figure 66. Cti Biopharma Revenue Growth Rate in Cell Theraputics Business (2016-2021) Figure 67. Atara Biotherapeutics, Inc Revenue Growth Rate in Cell Theraputics Business (2016-2021) Figure 68. Adaptimmune Revenue Growth Rate in Cell Theraputics Business (2016-2021) Figure 69. Bottom-up and Top-down Approaches for This Report Figure 70. Data Triangulation Figure 71. Key Executives Interviewed

Bristol-Myers Squibb Company (Celgene) Bluebird Bio Crispr Therapeutics Roche (Spark Therapeutics) PTC Therapeutics Moderna Therapeutics Quanterix Brainstorm Cell Therapeutics Inc. Lineage Cell Therapeutics Cti Biopharma Atara Biotherapeutics, Inc Adaptimmune